ExPrimary’s health care technology aims to impact ‘every human’
Via the Rochester Business Journal
June 3, 2020
Advancing personalized health care is the mission of ExPrimary, a startup company in NextCorps’ Luminate NY program. By improving access to bioanalytical tools and information, ExPrimary strives to help consumers identify and catch diseases at an earlier, more treatable stage.
ExPrimary is one of 10 finalist companies with optics, imaging and photonics-enabled technologies working inside the Luminate NY accelerator. The $25 million program, which is funded by the Finger Lakes Forward Upstate Revitalization Initiative, provides each finalist with an immediate investment of $100,000 and months of support to speed the commercialization of their technologies and businesses. On Demo Day in September, they will compete for up to $2 million in follow-on funding.
“Health care is changing at a rapid pace as more innovative products and methodologies become available. But the process of moving these innovations out of the lab into trials and then through regulatory procedures before commercialization can even take place can be daunting,” said Sujatha Ramanujan, managing director of Luminate. “We’re working with healthcare startups like ExPrimary to help them accelerate their pace and foster the partnerships critical to advancing their mission. Many of these rich resources reside here in the Finger Lakes region with our medical and research universities, benchmark hospital systems and manufacturers that specialize in opto-photonics and electronics.”
ExPrimary is developing a suite of high performing bioanalytical instrumentation as well as state-of-the-art assay content at a less costly rate compared with existing products on the market. The product uses an iOS mobile operating system, which is a critical reason for an expected three- to five-fold expansion of a $30 billion market.